Aliasgar Esmail
Impact in
- Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 2%
Papers in
-
- Tuberculosis Research and Epidemiology 40
- SARS-CoV-2 and COVID-19 Research 10
- HIV/AIDS Research and Interventions 9
- COVID-19 Clinical Research Studies 8
- Epidemiology 24
- Mycobacterium research and diagnosis 10
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Pneumonia and Respiratory Infections 6
- Co-authors
- Keertan Dheda (60 shared papers)Jason D. Limberis (8 shared papers)Greg Calligaro (10 shared papers)Richard Meldau (10 shared papers)Grant Theron (5 shared papers)Robin M. Warren (11 shared papers)Lucas Smith (4 shared papers)Suzette Oelofse (14 shared papers)
- Journals
- International Journal of Infectious Diseases (8 papers)Open Forum Infectious Diseases (5 papers)The Lancet Respiratory Medicine (5 papers)Journal of Clinical Microbiology (3 papers)American Journal of Respiratory and Critical Care Medicine (3 papers)
- Partner nations
- South AfricaUnited KingdomUnited States
In The Last Decade
Aliasgar Esmail
82 papers receiving 4.4k citations
Aliasgar Esmail's Hit Papers
Peers
Comparison fields: 5 of 140
- Infectious Diseases 3.5k
- Modeling and Simulation 178
- Epidemiology 1.2k
- Health 262
- Molecular Medicine 85
Countries citing papers authored by Aliasgar Esmail
This map shows the geographic impact of Aliasgar Esmail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliasgar Esmail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliasgar Esmail more than expected).
Fields of papers citing papers by Aliasgar Esmail
This network shows the impact of papers produced by Aliasgar Esmail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliasgar Esmail. The network helps show where Aliasgar Esmail may publish in the future.
Co-authors
The 25 scholars most cited alongside Aliasgar Esmail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant Hit paper breakdown → | 2021 | 905 |
| 2 | The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis Hit paper breakdown → | 2017 | 510 |
| 3 | Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis Hit paper breakdown → | 2018 | 497 |
| 4 | Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant Hit paper breakdown → | 2021 | 472 |
| 5 | 2017 | 248 | |
| 6 | 2022 | 179 | |
| 7 | 2016 | 114 | |
| 8 | 2017 | 103 | |
| 9 | 2018 | 96 | |
| 10 | 2019 | 94 | |
| 11 | 2018 | 85 | |
| 12 | 2017 | 61 | |
| 13 | 2021 | 54 | |
| 14 | 2016 | 54 | |
| 15 | 2020 | 53 | |
| 16 | 2022 | 53 | |
| 17 | 2021 | 50 | |
| 18 | 2015 | 48 | |
| 19 | 2023 | 48 | |
| 20 | 2019 | 39 |
About Aliasgar Esmail
Aliasgar Esmail is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Virology, having authored 91 papers that have together received 4.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (40 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Mycobacterium research and diagnosis (10 papers), HIV/AIDS Research and Interventions (9 papers), COVID-19 Clinical Research Studies (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Pneumonia and Respiratory Infections (6 papers) and Infectious Diseases and Tuberculosis (5 papers). The work is most often cited by research in Infectious Diseases (3.5k citations), Modeling and Simulation (178 citations), Epidemiology (1.2k citations), Health (262 citations) and Molecular Medicine (85 citations). Aliasgar Esmail has collaborated with scholars based in South Africa, United Kingdom and United States. Frequent co-authors include Keertan Dheda, Jason D. Limberis, Greg Calligaro, Richard Meldau, Grant Theron, Robin M. Warren, Lucas Smith, Suzette Oelofse, Rouxjeane Venter and Edson Makambwa. Their work appears in journals such as International Journal of Infectious Diseases, Open Forum Infectious Diseases, The Lancet Respiratory Medicine, Journal of Clinical Microbiology and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.